Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells (Oncotarget (2018) 9 (33368-33381) DOI: 10.18632/oncotarget.26077)

Research output: Contribution to journalErratum

Abstract

Contis-Montes de Oca et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This article has been corrected: The correct author list is given below: Arturo Contis-Montes de Oca 1,* , Estefanía Rodarte-Valle 2,* , Martha Cecilia Rosales-Hernández 2 , Edgar Abarca-Rojano 3 , Saúl Rojas-Hernández 1 , Manuel Jonathan Fragoso-Vázquez 4 , Jessica Elena Mendieta-Wejebe 2 , Ana María Correa-Basurto 2 , Ismael Vázquez-Moctezuma 2 and José Correa-Basurto 2,5 .
Original languageAmerican English
Pages (from-to)1225
Number of pages1
JournalOncotarget
StatePublished - 1 Sep 2018

    Fingerprint

Cite this